Home
About
Overview
Sharing Data
ORCID
Help
History (54)
Escherichia coli O104
Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome through Modulation of Microbiome in the Gut-Lung Axis.
Bone Morphogenetic Protein 3
Human kallistatin administration reduces organ injury and improves survival in a mouse model of polymicrobial sepsis.
A Novel Aza-MBP Altered Peptide Ligand for the Treatment of Experimental Autoimmune Encephalomyelitis.
See All 54 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A Novel Aza-MBP Altered Peptide Ligand for the Treatment of Experimental Autoimmune Encephalomyelitis.
A Novel Aza-MBP Altered Peptide Ligand for the Treatment of Experimental Autoimmune Encephalomyelitis. Mol Neurobiol. 2018 01; 55(1):267-275.
View in:
PubMed
subject areas
Animals
Aza Compounds
Cell Line
Encephalomyelitis, Autoimmune, Experimental
Male
Mice
Myelin Basic Protein
Treatment Outcome
authors with profiles
Azizul Haque
Craig Cano Beeson